Porphyria cutanea tarda symptomatica is clinically characterized by fragility of the skin and blisters on areas exposed to the sun. These frequently ulcerate and lead to scarring. Hypertrichosis and hyperpigmentation are common. The disease generally manifests itself in middle or later life. Males are much more commonly affected than females.
Chemically the disease is characterized by the excretion of large amounts of uroporphyrin and lesser amounts of coproporphyrin in the urine. The excretion of delta-aminolevulinic acid (ALA) may be slightly increased but the excretion of porphobilinogen is normal. The faecal excretion of coproporphyrin and of protoporphyrin is usually slightly increased.
The liver of patients with manifest porphyria cutanea tarda contains large amounts of preformed porphyrins, predominantly uroporphyrin (Schmid, Schwartz, and Watson, 1954) , which emits a strong red autofluorescence in ultraviolet light. In some studies direct examination of liver biopsy specimens macroscopically under the ultraviolet light of a Wood's lamp consistently showed red fluorescence in patients with the disease (Braun, and Berman, 1959;  Received for publication 5 March 1969 Lamont, Hathorn, and Joubert, 1961; Uys and Eales, 1963) . The diagnostic value of fluorescence microscopy of liver biopsy sections has been stressed (Niebauer, 1964) but the real results have been conflicting (Hickman, Saunders, and Eales, 1967; Uys and Eales, 1963) , probably due to unsuitable histological methods (Uys and Eales, 1963) .
In a study of various methodological, morphological, and quantitative aspects of liver cell fluorescence in porphyria cutanea tarda (Enerback, and Lundvall, 1969) we found that smears from fine needle aspiration biopsy specimens could be used for fluorescence microscopy study. This type of biopsy is easy to perform and can be done serially without undue risk if there is no bleeding tendency. We, therefore, studied a comparatively large number of patients by this method. We also studied the correlation between porphyrin excretion and hepatic fluorescence intensity and between the clinical stage of the disease and fluorescence intensity.
needles (10-15 cm) with an outer diameter of 0 7 mm are used. After local anaesthesia the puncture is performed in the mid-axillary line in a suitable intercostal space (usually the ninth) while the patient holds his breath. The needle is rapidly introduced through the liver parenchyma during continuous strong aspiration, which should be interrupted as soon as the tip of the needle has left the liver; if aspiration is maintained after the tip of the needle has left the skin the specimen will be lost into the syringe. The aspirate, consisting of blood, tissue fluid, tissue cells, and minute tissue particles, is immediately blown out on to a slide. The tiny drop is distributed on to several slides in thin short smears and allowed to dry in air. This technique has been described in detail by Soderstrom (1966) .
The fluorescence microscopy examination was performed on the unfixed smears within a few hours after the biopsy. Fluorescence microscopy was performed with a Zeiss fluorescence microscope using an Osram HBO 200 high pressure mercury arc, equipped with a Schott BG 12 primary filter, as light source. The fluorescent light was filtered through a Zeiss 50 secondary filter transmitting above 500 nm. Dark field condensers were used. For fluorescence photomicrographs Kodak high-speed Ektachrome films of daylight type or Kodak TriX films were used at exposure times of one half to 2 minutes.
The fluorescence was arbitrarily graded from 0 to 4. Urinary excretion of uroporphyrin and coproporphyrin was determined by the technique of Askevold (1951) . To ensure conversion of precursor to coproporphyrin, an iodine wash according to the method of Watson, Pimenta de Mello, Schwartz, Hawkinson, and Bossenmaier (1951) was used. Quantitative determinations of coproporphyrin and protoporphyrin in faeces were made according to the method of Holti, Rimington, Tate, and Thomas (1958) , using the formula given by Rimington and Sveinsson (1950) for the calculations. The extinction constants and corrections recommended by With (1955) were used. Quantitative urinary ALA and porphobilinogen determinations were performed according to the method of Mauzerall and Granick (1956) .
The phlebotomy treatment, introduced by Ippen (1960) , which in our series was consistently associated with clinical and partial biochemical remission, has been described elsewhere (Lundvall and Weinfeld, 1968) .
PATIENTS
The control series comprised 22 alcoholics in whom biopsy was performed using thick and fine needles. Study on thick-needle biopsy sections revealed cirrhosis in two control patients. In the others steatosis was found in most cases. The porphyric series comprised 19 patients (Table I ). Eight had typical clinical and biochemical signs of manifest porphyria cutanea tarda at the start of the study. Some of these were examined for hepatic porphyrin fluorescence before, during, and after phlebotomy at various stages of clinical activity. Eleven patients had the disorder clinically latent, but all had earlier had typical signs of manifest porphyria cutanea tarda. In eight of these clinical and partial biochemical remission had been induced by phlebotomy. Three patients had active disease some years before but had improved spontaneously.
RESULTS
With the technique described the smears macroscopically looked like bone marrow smears. Microscopically the hepatocytes were mainly found at the end of the smear, most occurring as small cell groups. At the end of the smears small lumps of liver tissue containing several layers of liver cells were seen. In controls the liver cells exhibited a dull green autofluorescence but the lumps of liver tissue fluoresced more brightly green. Blood cells fluoresced weakly green or not at all. In a few control specimens yellow or orange fluorescence of lipofuscin granules was seen. In small peripheral areas of the tissue lumps in control specimens a dull red colour sometimes appeared. Examination of these areas in transmitted light showed that they contained a layer of dried red blood cells, and this colour was quite different from the bright red fluorescence in specimens from porphyrics.
In specimens from control subjects no red autofluorescence of a porphyrin character was present except in those of one subject (grade 3). He was a 58-year-old alcoholic. He had never had skin symptoms. The urinary excretion of uroporphyrin was definitely increased (0 39-0 37 mg/day) and was in the range of the patients with latent porphyria cutanea tarda. Urinary excretion of coproporphyrin and precursors was normal.
In all specimens from porphyric patients a bright red fluorescence was found. In specimens with strong or moderate intensity a diffuse red background was frequently observed. This was probably due to diffusion of porphyrins from liver cells. With growing experience it was found that a reproducible fluorescence quantitation into five grades could be achieved if both fluorescence intensity and distribution were taken into consideration (Enerback and Lundvall, 1969 The red fluorescence of the liver cells faded fairly rapidly during persistent illumination. In specimens with fluorescence of grade 1 to grade 3 the fluorescence was usually extinguished after one to two minutes' persistent illumination. Therefore only smears with the highest grade of fluorescence could be illuminated long enough for photomicrography. On the other hand the fading was never so strong as to interferewith the quantification of the fluorescence.
Fluorescent liver cells and a fluorescent lump of liver tissue are illustrated in Figures 1 and 2 .
The results of the fluorescence grading and biochemical porphyrin analysis of the excreta of the patients with porphyria cutanea tarda are shown in Table I . Fluorescence of grades 3-4 was noted in all untreated patients. In four subjects the fluorescence was estimated before phlebotomy and during and/or after treatment. The fluorescence diminished from grade 3 to grade 1 in one patient (A.Go) and from grade 4 to grade 3 in two patients (O.I. and D.A.). In one (I.A.) the fluorescence increased from grade 3 to grade 4 during treatment. After further phlebotomies fluorescence of the pretreatment level (grade 3) was found and later on it diminished to grade 2.
The relation between clinical activity of the porphyric disease and fluorescence grading is shown in Figure 3 . Patients with manifest disease had fluorescence of grades 3 to 4. In patients with clinically latent disease grades 1 and 2 were most frequent but gradings of 3 to 4 were also encountered.
The relationship between fluorescence and urinary porphyrin excretion is shown in Figure 4 . The uroporphyrin excretion in patients with fluorescence of grades 1 to 2 was low (1 20 mg per day or less). In patients with grade 3 to 4 all levels of porphyrin excretion were encountered.
COMMENT
The smears can be examined immediately after drying without further treatment. If mounting and cover glasses are preferred for optical reasons, watercontaining media such as buffered glycerol must be avoided since they cause a diffusion of the watersoluble porphyrins from the liver cells (Enerback and Lundvall, 1969) .
With the present method all patients with porphyria cutanea tarda, those with clinically manifest as well as those with clinically inactive disease, showed bright red fluorescence in the liver cells. It should be pointed out, however, that the fluorescence of the liver cell nuclei is probably artifactive and due to diffusion of porphyrins from the cytoplasm (Enerback and Lundvall, 1969) . The nuclear fluorescence is also present in thick needle biopsy sections but can be avoided by special precautions. Various attempts to avoid this diffusion in smears have been unsuccessful (Enerback and Lundvall, 1969) , but diffusion does not discredit the method as a diagnostic tool. The method is easy to perform and there is no need to fix the smears. The more laborious method of histological biopsy sections requires specific precautions for reproducible results (Enerback and Lundvall, 1969; Grafflin, 1942) and probably explains the absence of porphyrin fluorescence in liver biopsy sections from patients with porphyria cutanea tarda in some studies (Hickman et al, 1967; Uys and Eales, 1963) . Furthermore, conventional liver biopsy is not without risks. Using the fine needle biopsy technique,complicationsdue to puncture are practically non-existent and the procedure described may be used as a screening test for hepatic cutaneous porphyria. The finding of bright red fluorescence in the liver indicates hepatic porphyria either of the present form or of the variegate form ('mixed' porphyria or South African genetic porphyria). In the last the liver also contains increased amounts of preformed porphyrins (Schmid et al, 1954) . So far we have studied only one patient with the variegate form of hepatic porphyria; fluorescence of grade 2 was present. This patient had no clinical symptoms at the time of examination. In the differential diagnosis of hepatic cutaneous porphyria chemical analyses of urine and faeces should be performed. Urinary coproporphyrin and uroporphyrin may be increased in both conditions but in symptomatic porphyria cutanea tarda gross uroporphyrinuria is characteristic of the active phase. Urinary porphyrin may be normal in porphyria variegata but when raised coproporphyrin usually exceeds uroporphyrin. The faecal porphyrins in porphyria variegata are markedly increased, protoporphyrin usually exceeding coproporphyrin. In porphyria cutanea tarda coproporphyrin usually exceeds protoporphyrin. Furthermore, in porphyria variegata acute attacks of the same type as in porphyria acuta intermittens occur. During acute attacks the urinary excretion of porphyrin precursors is increased. In non-cutaneous hepatic porphyria (porphyria acuta intermittens) the liver contains increased amounts of precursors not giving rise to fluorescence. Weak hepatic fluorescence in occasional cases of this disease has, however, been reported (Schmid et al, 1954) .
Patients with manifest disease had fluorescence of grades 3-4 and patients with latent disease usually had grades 1-2. In single patients with latent disease, however, fluorescence of the highest grades were encountered. In general, the fluorescence decreased in conjunction with phlebotomy ( Fig. 3) (Enerback and Lundvall, 1969) . In the present series there was a relationship between the liver fluorescence and urinary porphyrin excretion; the mean uroporphyrin excretion of those with fluorescence of grades 1-2 was significantly lower than that of those with grades 3-4. Though fluorescence ofgrades 1-2 was always associated with low uroporphyrin excretion (0-08-1 20 mg/24 hr) grades 3-4 were compatible with both low and high uroporphyrin excretion (0-20-9 19 mg). It is probable that the rate of uroporphyrin excretion in urine is conditioned by the rate of uroporphyrin production and by the capacity of the liver to store porphyrin. It is conceivable that urinary uroporphyrin excretion is low until the capacity of the liver to store uroporphyrin is surpassed. If so, the estimation of hepatic fluorescence might be a more sensible diagnostic measure than routine chemical analysis of porphyrins in urine and faeces. This view is supported by the fact that two patients with latent porphyria cutanea tarda (after phlebotomy treatment) had red fluorescence in liver cells in spite of quantitatively normal porphyrin excretion. Fluorescence of grade 3 was found in one control subject. He had, however, biochemical findings compatible with latent porphyria cutanea tarda. In no other control patient was red fluorescence observed, but in single specimens yellow or orange fluorescence of lipofuscin granules was seen. These can, however, easily be identified because of their characteristic appearance.
In the periphery of the tissue lumps a zone of dull red fluorescence was sometimes observed, and examination in transmitted light revealed that it was composed of a layer of dried red blood cells. This colour was quite different from the bright red colour of the porphyrin fluorescence and was probably due to an absorption quenching of the tissue autofluorescence caused by the red blood cells (Enerback and Lundvall, 1969) .
Many drugs concentrate in the liver cells. So far, we do not know of any drug giving red fluorescence. Fluorescence in livers from subjects treated with drugs with unknown fluorescence properties should, however, be evaluated with the possibility of druginduced fluorescence in mind.
